ArticleThe Journal of biological chemistry2014

Modification of rifamycin polyketide backbone leads to improved drug activity against rifampicin-resistant Mycobacterium tuberculosis.

Aeshna Nigam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.